Cleerly (Cleerly Labs / Plaque Analysis)
Save to shortlistLast reviewed Oct 31, 2026 against the sources listed on this page · How we review
At a glance
Cleerly is an FDA-cleared AI platform that uses deep learning to analyze coronary CT angiography (CCTA) scans, automatically quantifying and characterizing coronary plaque (volume, composition,…
- FDA:
- 510(k) K261210
- Epic:
- Not on record
- Named users:
- 2 named in public reports
- Published study:
- Not on record
Description
Cleerly is an FDA-cleared AI platform that uses deep learning to analyze coronary CT angiography (CCTA) scans, automatically quantifying and characterizing coronary plaque (volume, composition, location), stenosis severity, and vessel-specific ischemia risk. It provides objective, reproducible coronary artery disease assessment to guide preventive and interventional decisions. In the CERTAIN trial, its AI quantitative plaque analysis reduced unnecessary downstream testing by 37%.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is Cleerly (Cleerly Labs / Plaque Analysis) FDA cleared?
- The public FDA database has one record that our team matched to Cleerly (Cleerly Labs / Plaque Analysis). The most recent is 510(k) K261210 (Cleerly Plaque), decided Jul 2026. Check that the cleared use matches how you plan to use it.FDA record K261210
- Which health systems use Cleerly (Cleerly Labs / Plaque Analysis)?
- Linked public reports name 2 organizations: FirstHealth and Lee Health. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.FirstHealth (Greater Fayetteville Business Journal) Lee Health (Florida Hospital News and Healthcare Report)
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Regulatory submission summary
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
2 organizationsOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Last checked Oct 31, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Cardiology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
Website FDA RecordFDA database records
- K261210 · 510(k) · Jul 2026Cleerly Plaque
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (4)Show
Dated events on this listing's public record, newest first.
Developer
Cleerly, Inc. (founded by Dr. James K. Min)
Cleerly, Inc.
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →